# Medtronic

**Source:** https://geo.sig.ai/brands/medtronic  
**Vertical:** Healthcare Tech  
**Subcategory:** Enterprise  
**Tier:** Leader  
**Website:** medtronic.com  
**Last Updated:** 2026-04-14

## Summary

World's largest medical device company with $32.4B FY2024 revenue; Hugo robotic surgery challenges Intuitive Surgical; MiniMed automated insulin system; Patient Monitoring spin-off 2024; NYSE: MDT.

## Company Overview

Medtronic plc is the world's largest medical device company, founded in 1949 by Earl Bakken and Palmer Hermundslie in a Minneapolis, Minnesota garage—where Bakken invented the first wearable external pacemaker—and now incorporated in Ireland with operational headquarters in Dublin, trading on NYSE (MDT). The company generated approximately $32.4 billion in revenues for fiscal year 2024 (ending April 26, 2024) under CEO Geoff Martha, spanning cardiovascular, neuroscience, surgical, and diabetes therapy technologies. Medtronic's 2015 acquisition of Covidien for $49.9 billion—at the time the largest medical device merger in history—added surgical instruments, patient monitoring, and respiratory interventions while enabling Irish incorporation that reduced the company's effective tax rate. In 2024, Medtronic announced the spin-off of its Patient Monitoring & Respiratory Interventions segment as an independent company (NewCo), sharpening focus on higher-margin, high-growth therapy areas.

Medtronic's cardiovascular portfolio—the largest revenue contributor—includes implantable cardiac defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, cardiac ablation systems (Affera and Arctic Front cryoablation), transcatheter heart valves (Evolut TAVR competing with Edwards Lifesciences), and electrophysiology mapping systems. The neuromodulation portfolio includes deep brain stimulation (DBS) systems for Parkinson's disease and essential tremor, spinal cord stimulation for chronic pain, and neurovascular intervention catheters. Hugo, Medtronic's soft-tissue robotic-assisted surgery system, received CE Mark and international approvals and is being deployed to challenge Intuitive Surgical's da Vinci monopoly in soft-tissue robotic surgery—a market Medtronic is pursuing aggressively given its global hospital relationships and installed base of surgical products.

In 2025-2026, Medtronic competes with Abbott Laboratories (cardiac rhythm), Edwards Lifesciences (structural heart valves), Boston Scientific (cardiac electrophysiology, endoscopy), Stryker (neurosurgery, spinal), and Intuitive Surgical (robotic surgery) across its major therapy areas. The diabetes segment's MiniMed 780G automated insulin delivery system competes with Insulet's Omnipod and Tandem Diabetes Care's Control-IQ in the closed-loop insulin pump market, with continuous glucose monitor integration through partnerships with Dexcom and Abbott. The company's global presence—generating approximately 45% of revenues outside the United States—provides diversification but also currency translation headwinds that have pressured reported growth versus constant-currency performance.

## Frequently Asked Questions

### What does Medtronic do?
Medtronic plc is the world's largest medical device company by revenue, developing and manufacturing medical technology, services, and solutions for chronic diseases. The company operates in four main business segments: Cardiovascular (cardiac rhythm management, structural heart, coronary and peripheral vascular), Neuroscience (spinal technologies, brain therapies, neurovascular), Medical Surgical (surgical tools, patient monitoring, robotic-assisted surgery), and Diabetes (insulin pumps, continuous glucose monitoring). Medtronic serves more than 79 million patients annually across 150+ countries with over 90,000 employees worldwide.

### When was Medtronic founded?
Medtronic was founded on April 29, 1949, by Earl Bakken and Palmer Hermundslie as a medical equipment repair shop in a garage in Minneapolis, Minnesota. The company's breakthrough moment came in 1957 when Earl Bakken developed the first wearable, battery-powered cardiac pacemaker, followed by the 1960 introduction of the first implantable pacemaker that revolutionized cardiac care and transformed Medtronic from a small repair business into a global medical device leader.

### Where is Medtronic headquartered?
Medtronic has dual headquarters: the company's legal headquarters is in Dublin, Ireland (established through the 2015 Covidien acquisition), while its operational headquarters remains in Minneapolis, Minnesota, where the company was founded in 1949. Medtronic operates in more than 150 countries with major operations across North America, Europe, Asia-Pacific, and Latin America.

### Who are Medtronic's customers?
Medtronic serves a broad customer base including hospitals and health systems, cardiac electrophysiologists and cardiologists, neurosurgeons and spine surgeons, endocrinologists and diabetes care providers, vascular and endovascular specialists, general and minimally invasive surgeons, pain management physicians, and patients using home-based medical devices like insulin pumps and continuous glucose monitors. The company serves 79+ million patients annually across diverse medical specialties.

### How large is Medtronic?
Medtronic is the world's largest medical device company by revenue, with fiscal year 2025 worldwide revenue of $33.537 billion, over 90,000 employees, operations in more than 150 countries, and serving 79+ million patients annually. The company generates free cash flow of approximately $5.2 billion annually and invests $2.7 billion in research and development. Medtronic is among the top 10 most valuable healthcare brands worldwide.

### What makes Medtronic different from competitors?
Medtronic differentiates itself through unmatched breadth and depth across medical device categories, from the world's smallest pacemaker to advanced robotic surgery platforms. The company's competitive advantages include 76 years of medical device innovation heritage dating to the first pacemaker, $2.7 billion annual R&D investment driving breakthrough technologies, leadership positions in cardiac rhythm management, spinal technologies, and diabetes care, comprehensive clinical evidence demonstrating superior patient outcomes, global scale enabling market access across 150+ countries, and the Medtronic Mission adopted in 1960 that directs the company to prioritize human welfare and patient-centered innovation.

### Who are Medtronic's main competitors?
Medtronic's primary competitors vary by business segment and include Abbott Laboratories (cardiovascular devices, diabetes technology), Boston Scientific (cardiac rhythm management, interventional cardiology, neuromodulation), Johnson & Johnson through Ethicon and DePuy Synthes (surgical devices, orthopedics), Edwards Lifesciences (structural heart therapies), Stryker (surgical equipment, neurotechnology, spine), Becton Dickinson, Philips Healthcare, Zimmer Biomet, and Smith & Nephew. In the growing surgical robotics market, Medtronic competes with Intuitive Surgical, Johnson & Johnson's Ottava platform, and others.

### Is Medtronic publicly traded?
Yes, Medtronic plc is publicly traded on the New York Stock Exchange under ticker symbol 'MDT.' The company has been publicly traded since its 1977 NYSE listing and is included in major stock market indices. Medtronic is widely held by institutional and individual investors and provides regular financial reporting, quarterly earnings calls, and investor relations communications.

### Does Medtronic pay dividends?
Yes, Medtronic pays quarterly cash dividends to shareholders and has a long history of dividend payments and increases. The company announced dividend increases in fiscal 2024 and 2025, reflecting strong cash generation and commitment to returning capital to shareholders. Medtronic balances dividend payments with substantial reinvestment in R&D ($2.7 billion annually) and strategic acquisitions.

### Is Medtronic hiring?
Yes, Medtronic actively recruits talent globally across its 90,000+ employee base in more than 150 countries. The company seeks engineers (biomedical, electrical, mechanical, software), clinical specialists, sales and marketing professionals, manufacturing and operations experts, regulatory and quality professionals, data scientists and software developers, R&D researchers, and corporate functions. Medtronic offers comprehensive benefits, professional development, career advancement opportunities, and a mission-driven culture. Interested candidates can explore opportunities at Medtronic's careers portal: medtronic.wd1.myworkdayjobs.com/MedtronicCareers.

### What are Medtronic's future plans?
Medtronic's strategy focuses on accelerating innovation to drive approximately 5% organic revenue growth in fiscal 2026, expanding in high-growth markets including structural heart therapies, surgical robotics, diabetes automated insulin delivery, and neuromodulation. The company plans to separate its Diabetes business into a fully independent company to enable focused investment and growth strategies. Key initiatives include advancing AI and machine learning in medical devices, expanding robotic-assisted surgery through the Hugo platform and Embrace Gynecology study, securing reimbursement for innovative therapies like renal denervation for hypertension, and pursuing strategic M&A to strengthen capabilities in priority areas.

### How can I contact Medtronic?
Medtronic's operational headquarters is located in Minneapolis, Minnesota, with legal headquarters in Dublin, Ireland. For general inquiries, visit the company's website at www.medtronic.com which provides contact information for various regions, customer service, and departments. For investor relations inquiries, access the investor relations section at investorrelations.medtronic.com. For career inquiries, email DLAEMSUPPORTHELP@medtronic.onmicrosoft.com or visit the careers website. For product support and clinical inquiries, healthcare professionals can contact regional Medtronic offices or access technical support through the main website.

## Tags

b2b, healthtech, manufacturing, saas, public

---
*Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*